Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.

Over 6000 publications, 1000 cell lines and primary cells available.

Order by :  
Found 5890 results :
Cell Linein vitro
in vivo		Delivered MoleculeReagentResults & Citations
HEK293SF-3F6in vitroDNAFectoVIR-AAV
Tzimou, K.. et al. (2025)

Gene Ther . ,
Mixture design as a tool for improving full-to-empty particle ratios across various GOIs in rAAV production
More details
HEK-293Tin vitroDNAFectoVIR-AAV
Zhu, Y.. et al. (2025)

Front Oncol. 15, 1566584
Adeno-associated virus vector modification based on directed evolution technology for gene therapy targeting head and neck squamous cell carcinoma
More details
HEK-293-F, VPC 2.Oin vitroDNAFectoVIR-AAV
Hirohata, K.. et al. (2025)

Eur Biophys J . ,
Use of cesium chloride density gradient ultracentrifugation for the purification and characterization of recombinant adeno-associated virus
More details
HEK-293S GnTIin vitroDNAFectoPRO
Matsuzaki, Y.. et al. (2025)

Commun Biol . 8, 957
Structural insights into ligand recognition and G protein preferences across histamine receptors
More details
Expi293Fin vitroDNAFectoPRO
Filsinger Interrante, M. V.. et al. (2025)

ACS Chem Biol . 20, 1470-1480
Utilizing Machine Learning to Improve Neutralization Potency of an HIV-1 Antibody Targeting the gp41 N-Heptad Repeat
More details
CHOin vitroDNAFectoPRO
Chen, S.. et al. (2025)

J Immunother Cancer . 13, e012144
Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer
More details
Expi293Fin vitroDNAFectoPRO
Wang, X.. et al. (2025)

Adv Mater. , e2500872
De Novo Design of Integrin α5β1 Modulating Proteins to Enhance Biomaterial Properties
More details
Expi 293in vitroDNAFectoPRO
Adams, J. J.. et al. (2025)

Protein Sci . 34, e70145
Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation
More details
HEK-293Tin vitroDNAPEIpro
Andorko, J. I.. et al. (2025)

Mol Ther . S1525-0016, 00487-3
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation
More details
HEK-293Tin vitroDNAPEIpro
Soula, A.. et al. (2025)

Mol Ther Methods Clin Dev . 33, 101496
The manufacture of AAV for gene therapy applications using a closed, semi-automated hollow-fiber bioreactor
More details
« Previous Results
Next Results »